|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Real Estate Investment Property, Net | ||||||||||||||||||||
| Developed Hotel Properties | ||||||||||||||||||||
| Hotel Properties Under Development | ||||||||||||||||||||
| Total real Estate Investment Property, Net | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Right of use asset, net | ||||||||||||||||||||
| Hotel receivables (net of allowance for doubtful accounts of $300 and $280, respectively) | ||||||||||||||||||||
| Hotel receivables (net of allowance for doubtful accounts of $296 and $261, respectively) | ||||||||||||||||||||
| Deferred costs, net | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity: | ||||||||||||||||||||
| Mortgage debt, net | ||||||||||||||||||||
| Revolving credit facility | ||||||||||||||||||||
| Construction loan | ||||||||||||||||||||
| Unsecured term loan, net | ||||||||||||||||||||
| Accounts payable and accrued expenses (including $947 and $234 due to related parties, respectively) | ||||||||||||||||||||
| Lease liability, net | ||||||||||||||||||||
| Lease liability | ||||||||||||||||||||
| Distributions payable | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Preferred shares, $0.01 par value, 100,000,000 shares authorized; 4,800,000 and 4,800,000 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Common shares, $0.01 par value, 500,000,000 shares authorized; 46,565,171 and 47,708,587 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Noncontrolling Interests: | ||||||||||||||||||||
| Noncontrolling interest in Operating Partnership | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
